AstraZeneca · 21 hours ago
AAV Production Biology and Process Development Intern
AstraZeneca is seeking interns for their Alexion: AstraZeneca Rare Disease division. The role involves performing laboratory experiments to investigate AAV production and improve production conditions.
BiopharmaBiotechnologyHealth CareMedicalPharmaceuticalPrecision Medicine
Responsibilities
Perform laboratory experiments under the guidance of experienced scientists investigating the biology of AAV production to engineer improved production conditions
Perform experiments investigating novel plasmid designs for improved AAV plasmid quality
Analyze experimental data and contribute to interpretation of results
Prepare reports and presentations to communicate findings
Maintain accurate and detailed records of laboratory experiments and results
Adhere to safety protocols and contribute to a safe working environment
Qualification
Required
Junior and Master's students majoring in Bioengineering, Biochemistry, Molecular Biology, Chemical Engineering, Biotechnology, or a related field
Candidates must have an expected graduation date after August 2026
Required laboratory skills include pipetting, mammalian cell culture, molecular biology techniques (PCR, gel electrophoresis), analyzing and interpreting experimental data
US Work Authorization is required at time of application
Ability to report onsite to the Cambridge, MA site 5 days per week
Preferred
Preferred skills include DNA cloning, plasmid purification, AAV or other viral vectors, statistical software, Flow cytometry, genome engineering
Familiarity with the innate immune system is a plus
Enthusiasm for collaboration, cross-functional projects, public speaking, and presentation design
Benefits
Short-term incentive bonus opportunity
Equity-based long-term incentive program (salaried roles)
Retirement contribution (hourly roles)
Commission payment eligibility (sales roles)
Qualified retirement program [401(k) plan]
Paid vacation and holidays
Paid leaves
Health benefits including medical, prescription drug, dental, and vision coverage
Company
AstraZeneca
AstraZeneca is a pharmaceutical company that discovers, develops, manufactures, and markets prescription medicines. It is a sub-organization of Investor.
Funding
Current Stage
Public CompanyTotal Funding
$5.26B2024-07-30Post Ipo Debt· $1.51B
2023-02-28Post Ipo Debt· $2.25B
2023-02-24Post Ipo Debt· $1.5B
Leadership Team
Recent News
2026-01-09
2026-01-09
News Powered by Cision
2026-01-08
Company data provided by crunchbase